You are here Home Resources and guidance Sponsors Revelare DX Pty Ltd Regulatory activities for this sponsor. Listen Print Share LinkedIn (Twitter) Facebook Email Loading... Type ARTG (1) Date 2025 (1) Search Sponsor content1 result(s) found, displaying 1 to 1 Revelare DX Pty Ltd - Yuwell CT3 CGM system - Invasive interstitial-fluid glucose monitoring system (521193) 3 December 2025 ARTG Australian Register of Therapeutic Goods (ARTG) information for Revelare DX Pty Ltd - Yuwell CT3 CGM system - Invasive interstitial-fluid glucose monitoring system.
Revelare DX Pty Ltd - Yuwell CT3 CGM system - Invasive interstitial-fluid glucose monitoring system (521193) 3 December 2025 ARTG Australian Register of Therapeutic Goods (ARTG) information for Revelare DX Pty Ltd - Yuwell CT3 CGM system - Invasive interstitial-fluid glucose monitoring system.